Menghis Bairu, MD is an internationally recognized physician, scientist, entrepreneur and philanthropist whose career spans over three decades in the biotechnology industry with Genentech/Roche; Elan; J&J; Serenus Biotherapeutics and BioUsawa Biotechnology. As co-founder, CEO and President of BioUsawa, Dr. Bairu leads an ambitious mission to transform healthcare access across Africa and Low-Middle-Income-Countries by producing affordable, high-quality life-saving biologics. BioUsawa focuses on critical therapeutic areas, including ophthalmology, oncology, autoimmunity, and infectious diseases, for which cost barriers limit access to essential biologics. BioUsawa aims to deliver these treatments at ≤20% of Western reference prices, establishing Africa’s first biosimilar-manufacturing hub and setting new standards for accessible healthcare in underserved regions. He emphasizes local talent development, strategic partnerships, and robust regulatory engagement, fostering a sustainable healthcare ecosystem.
